(Philadelphia,
PA) - Victor Hatini, PhD, has joined the Department
of Cell and Developmental Biology at the University
of Pennsylvania School of Medicine as an Assistant Professor.
Dr. Hatini's research addresses the underlying mechanisms
responsible for excessive growth of epithelial tissues
covering various parts of the body. To solve this, he
is using molecular genetic approaches in the fruit fly
Drosophila melanogaster to define molecular pathways
that simultaneously affect epithelial architecture and
cell proliferation. Dr. Hatini has been published in
the Journal of Biological Chemistry, Developmental
Biology, Development, Genes & Development, Molecular
Cell, Developmental Dynamics and Progress in
Clinical and Biological Research.
He earned his Bachelor of Science (B.Sc.) degree in
Biology (cum laude) from Hebrew University in Israel
and his Master of Science (M.Sc.) degree in Molecular
Genetics and Virology from the Weizmann Institute of
Science, also in Israel. Dr. Hatini earned his PhD in
Molecular Biology from Cornell University Medical College
in New York City. He performed fellowships at the Weizman
Institute of Science, Cornell University Medical College
(Memorial Sloan-Kettering Division), Rockefeller University
and the University of Pennsylvania.
Dr. Hatini is a member of The Genetic Society of America
and was last invited to lecture at The Joseph Stokes
Jr. Research Institute at The Children's Hospital of
Philadelphia, on the topic, 'Transcriptional control
of epidermal patterning and epithelial morphogenesis.'
# # #
.
Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, excellence in patient care, and community service. The organization consists of the University of Pennsylvania Health System and Penn’s Raymond and Ruth Perelman School of Medicine, founded in 1765 as the nation’s first medical school.
The Perelman School of Medicine is consistently among the nation's top recipients of funding from the National Institutes of Health, with $550 million awarded in the 2022 fiscal year. Home to a proud history of “firsts” in medicine, Penn Medicine teams have pioneered discoveries and innovations that have shaped modern medicine, including recent breakthroughs such as CAR T cell therapy for cancer and the mRNA technology used in COVID-19 vaccines.
The University of Pennsylvania Health System’s patient care facilities stretch from the Susquehanna River in Pennsylvania to the New Jersey shore. These include the Hospital of the University of Pennsylvania, Penn Presbyterian Medical Center, Chester County Hospital, Lancaster General Health, Penn Medicine Princeton Health, and Pennsylvania Hospital—the nation’s first hospital, founded in 1751. Additional facilities and enterprises include Good Shepherd Penn Partners, Penn Medicine at Home, Lancaster Behavioral Health Hospital, and Princeton House Behavioral Health, among others.
Penn Medicine is an $11.1 billion enterprise powered by more than 49,000 talented faculty and staff.